Afya (NASDAQ:AFYA) Sees Large Volume Increase

Afya Limited (NASDAQ:AFYA - Get Free Report) shares saw unusually-high trading volume on Tuesday . Approximately 142,768 shares were traded during mid-day trading, an increase of 12% from the previous session's volume of 126,908 shares.The stock last traded at $17.72 and had previously closed at $17.92.

Wall Street Analyst Weigh In

AFYA has been the subject of a number of analyst reports. Citigroup initiated coverage on shares of Afya in a research report on Monday, January 29th. They issued a "neutral" rating and a $23.00 price target for the company. Morgan Stanley downgraded shares of Afya from an "overweight" rating to an "equal weight" rating and lifted their price target for the company from $20.50 to $23.00 in a research report on Monday, January 22nd.

Get Our Latest Stock Analysis on Afya

Afya Price Performance

The business's 50 day moving average is $19.97 and its 200-day moving average is $19.30. The firm has a market capitalization of $1.67 billion, a P/E ratio of 20.77, a PEG ratio of 0.57 and a beta of 0.97. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 0.45.

Afya (NASDAQ:AFYA - Get Free Report) last announced its quarterly earnings data on Thursday, March 14th. The company reported $0.34 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.32 by $0.02. The business had revenue of $147.35 million for the quarter, compared to analysts' expectations of $141.83 million. Afya had a net margin of 13.54% and a return on equity of 15.88%. As a group, sell-side analysts predict that Afya Limited will post 1.54 EPS for the current fiscal year.


Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in AFYA. HBK Sorce Advisory LLC grew its stake in shares of Afya by 10.0% during the fourth quarter. HBK Sorce Advisory LLC now owns 11,044 shares of the company's stock worth $242,000 after buying an additional 1,000 shares during the last quarter. Daiwa Securities Group Inc. grew its stake in shares of Afya by 32.6% during the third quarter. Daiwa Securities Group Inc. now owns 4,145 shares of the company's stock worth $65,000 after buying an additional 1,020 shares during the last quarter. UBS Group AG grew its stake in shares of Afya by 48.4% during the fourth quarter. UBS Group AG now owns 3,151 shares of the company's stock worth $49,000 after buying an additional 1,027 shares during the last quarter. State Street Corp grew its stake in shares of Afya by 1.1% during the third quarter. State Street Corp now owns 95,845 shares of the company's stock worth $1,300,000 after buying an additional 1,034 shares during the last quarter. Finally, Lazard Asset Management LLC grew its stake in shares of Afya by 12.7% during the third quarter. Lazard Asset Management LLC now owns 16,312 shares of the company's stock worth $257,000 after buying an additional 1,840 shares during the last quarter. 88.02% of the stock is owned by institutional investors.

About Afya

(Get Free Report)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

Further Reading

→ The AI stock to buy right now (From StockEarnings) (Ad)

Should you invest $1,000 in Afya right now?

Before you consider Afya, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.

While Afya currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Featured Articles and Offers

Search Headlines: